Medicare Enrolled

Dr. Deborah Riney

Psychiatric/Mental Health Nurse Practitioner · Dallas, TX
Low-engagement
7777 FOREST LN, Dallas, TX 75230
9725664591
In practice since 2006 (19 years)
NPI: 1386653764 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Riney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Riney

Dr. Deborah Riney is a psychiatric/mental health nurse practitioner in Dallas, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Riney received a total of $6,637 from 31 pharmaceutical and/or device companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatric/mental health nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Riney is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $6,637 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,637
Total received (2021-2024)
Avg $1,659/year across 4 years
Top 5% in TX for psychiatric/mental health nurse practitioner
31
Companies
305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,637 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17
2023
$2,056
2022
$2,914
2021
$1,650

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc.
$920
Alkermes, Inc.
$788
Neurocrine Biosciences, Inc.
$719
AbbVie Inc.
$494
Lundbeck LLC
$392
ABBVIE INC.
$386
Janssen Pharmaceuticals, Inc
$383
Otsuka America Pharmaceutical, Inc.
$374
Neuronetics, Inc.
$273
Takeda Pharmaceuticals U.S.A., Inc.
$195
Merck Sharp & Dohme LLC
$185
Neos Therapeutics, LP
$164
Sunovion Pharmaceuticals Inc.
$153
Bausch Health US, LLC
$140
Teva Pharmaceuticals USA, Inc.
$139
Vanda Pharmaceuticals Inc.
$127
Supernus Pharmaceuticals, Inc.
$98
Noven Pharmaceuticals, Inc.
$96
Noven Therapeutics, LLC
$78
Tris Pharma Inc
$74
Eisai Inc.
$70
Axsome Therapeutics, Inc.
$62
Ironshore Pharmaceuticals Inc.
$62
Alfasigma USA, Inc.
$48
Avanir Pharmaceuticals, Inc.
$47
Corium, LLC
$47
JAZZ PHARMACEUTICALS INC.
$35
IDORSIA PHARMACEUTICALS US INC
$30
Almatica Pharma LLC
$21
Orexo US, Inc.
$20
OWP Pharmaceuticals, Inc.
$15
Top 3 companies account for 36.6% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Dayvigo · Dyanavel XR · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · Nuedexta · QELBREE · QUVIVIQ · Quillivant · REXULTI · SPRAVATO · SUNOSI · Secuado · Subvenite · TRINTELLIX · VRAYLAR · WELLBUTRIN · Xelstrym · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for psychiatric/mental health nurse practitioner in TX.

Looking for a psychiatric/mental health nurse practitioner in Dallas?
Compare psychiatric/mental health nurse practitioners in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse psychiatric/mental health nurse practitioners nearby

Geographic Context

Psychiatric/mental health nurse practitioners within 10 mi
765
Per 100K population
29.4
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Riney is a psychiatric/mental health nurse practitioner, with low-engagement industry engagement in the top 5% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Riney receive payments from pharmaceutical companies?
Yes. Dr. Riney received a total of $6,637 from 31 companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Riney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →